'I had to advocate for myself and see a few GPs before someone took it out and it came back as a melanoma,' she explained.

First clinical data for OAP-101, built on proprietary OmniAntigen™ Platform (OAP)OAP enables systematic immune reprogramming therapy (XIRT™) to overcome resistance of cold solid tumors to current ...

Late-stage development, KEYTRUDA combination potential, orphan drug advantages and multiple tumor expansion position IFx-2.0 for faster adoption and portfolio returns.Dublin, Oct. 13, 2026 (GLOBE ...

INTerpath-001 data to be presented in Presidential Symposium, featuring the first Phase 3 results for investigational ...

A new review in Molecular Cancer argues that microbes living inside tumors dynamically reprogram immunity and can determine ...

A retrospective study of 25 patients suggests that adding the anti-PD-1 antibody pucotenlimab to concurrent radiochemotherapy produced tumor responses and favorable survival figures in adults with ...

A real-world study of 8,391 patients found that autonomous artificial intelligence (AI) could free up enough clinical ...

Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.

For the fourth time in five seasons Athlone Town and Shelbourne square up to each other on a blue riband day for the women's domestic game.

Autonomous AI saved 2,851 clinician hours across two UK hospitals, creating capacity for more than 8,500 additional ...